Find the latest Albireo Pharma, Inc. (ALBO) stock quote, history, news and other vital information to help you with your stock trading and investing.

Albireo Pharma, Inc. (NASDAQ:ALBO) – Wedbush dropped their Q2 2021 earnings estimates for Albireo Pharma in a research report issued to clients and investors on Monday, March 1st. Wedbush analyst L. Moussatos now expects that the biopharmaceutical company will post earnings of ($1.60) per share for the quarter, down from their prior estimate of ($1.59). […]

View the latest ratings for ALBO. Albireo Pharma. stock was originally listed at a price of $2,160.00 in May 11, 2007. If you had invested in Albireo Pharma stock at $2,160.00, your return over the last 13 years would have been -98.37%, for an annualized return of -27.14%. 2021-02-05 · Albireo Pharma, Inc. Common Stock (ALBO) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Find the latest Albireo Pharma, Inc. (ALBO) stock quote, history, news and other vital information to help you with your stock trading and investing. Albireo Pharma Forecast Models Albireo Pharma time-series forecasting models is one of many Albireo Pharma's stock analysis techniquest aimed to predict future share value based on previously observed values.

Albireo pharma stock forecast

Is Albireo Pharma (NASDAQ:ALBO) a buy? Compare the latest price, visualised quantitative ratios, annual reports, historical dividends, pricing and company Real-time share price updates and latest news for Albireo Pharma Inc (NASDAQ: ALBO). Compare across sectors, industries & regions. Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Albireo Pharma Inc Stock Forecast NASDAQ:ALBO Price Target and Analyst Ratings. Most Recent Rating. Jefferies Financial Group is very positive to ALBO and gave it a "Positive - Buy" rating on March 26, 2021. The price target was set to $79.00 → $82.00. Last 30 Days.

Albireo Pharma stock price as been showing a rising tendency so we believe that similar market segments were very popular in the given time frame. Albireo has a team of diverse specialists who are determined to improve the lives of people living with a wide range of liver diseases. Find out more. According to the market data, Albireo Pharma Inc (ALBO) stock price is $35.96 and the 52 weeks low is $14.37, which means the Albireo Pharma Inc stock price is up 130.22% in the last 12 months.

Albireo Pharma currently has 8 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ALBO will outperform the market and that investors should add to their positions of Albireo Pharma. View the latest ratings for ALBO.

WARNING: Trend forecast is still in the development phase and should be used with caution. Albireo Pharma Inc Stock Price Forecast, "ALBO" Predictons for2021 About the Albireo Pharma, Inc. stock forecast Unlock SECRET Features HERE for $1! >> As of 2021 March 28, Sunday current price of ALBO stock is 34.390$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception). Analyst Forecasts According to 8 analysts, the average rating for Albireo Pharma stock is "Strong Buy." The 12-month stock price forecast is 73.00, which is an increase of 116.75% from the latest price.

See today’s analyst top recommended stocks >> Albireo Pharma (ALBO) In a report released today, Joseph Stringer from Needham assigned a Buy rating to Albireo Pharma… ALBO's price/sales ratio is 75.64; that's higher than the P/S ratio of 95.65% of US stocks. Albireo Pharma Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -32.7%, greater than the shareholder yield of only 7.29% of stocks in our set. 2021-02-25 Albireo Pharma, Inc. is an equal opportunity employer and does not discriminate against any applicant because of race, creed, color, age, national origin, ancestry, religion, gender, sexual orientation, disability, genetic information, veteran status, military status, application for military service or any other class protected by state or federal law. ALBIREO PHARMA, INC. : News, information and stories for ALBIREO PHARMA, INC. | Nasdaq: ALBO | Nasdaq 2021-03-04 Ever wondered how to buy stock in Albireo Pharma, Inc? We explain how and compare the best share dealing platforms. Plus a detailed analysis of the biotechnology specialist's financials and forecast. Albireo Pharma, Inc. (NASDAQ:ALBO) - Wedbush dropped their Q2 2021 earnings estimates for Albireo Pharma in a research report issued to clients and investors on Monday, March 1st. Wedbush analyst L. Moussatos now expects that the biopharmaceutical company will post earnings of ($1.60) per share for the quarter, down from their prior estimate of ($1.59).
Jobb hos hm

0 analysts have rated the stock as a Sell or Underperform. 2021-03-20 · Albireo Pharma, Inc. (ALBO) registered a 3.87% upside in the last session and has traded in the red over the past 5 sessions.

ALBIREO PHARMA INC - MAY OFFER, SELL SHARES OF COMMON STOCK HAVING AGGREGATE OFFERING PRICE OF UP TO $50 MILLION FROM TIME 1 Mar 2021 Albireo Pharma has an analyst consensus of Strong Buy, with a price also reiterated a Buy rating on the stock with a $73.00 price target. Вся информация про Albireo Pharma: цена акций Albireo Pharma, график котировок акций Albireo Pharma, дивиденды компании Albireo Pharma, новости In depth view into ALBO (Albireo Pharma) stock including the latest price, news, dividend history, earnings information and financials. 8 Apr 2021 Albireo Pharma Inc Share Price and News. Albireo is a clinical-stage biopharmaceutical company focused on the development and potential Albireo Pharma, Inc. Common Stock (ALBO) Revenue EPS : Previous 3 Years shares of Albireo Pharma Inc (NASDAQ:ALBO) at an average price of $40.00.
Angered invandrare

Albireo Pharma, Inc. Common Stock (ALBO) Revenue EPS : Previous 3 Years shares of Albireo Pharma Inc (NASDAQ:ALBO) at an average price of $40.00.

What price target have analysts set for ALBO? View research reports from Argus and trade ideas from Trading Central to understand future stock performances and find high performing trade ideas. Albireo Pharma Inc quote is equal to 33.525 USD at 2021-04-08. Based on our forecasts, a long-term increase is expected, the "ALBO" stock price prognosis for 2026-04-03 is 36.871 USD. With a 5-year investment, the revenue is expected to be around +9.98%.

Barn tvangstanker

Based on 7 analysts offering 12 month price targets for Albireo Pharma in the last 3 months. The average price target is $74.33 with a high forecast of $82.00 and a low forecast of $67.00. The average price target represents a 132.72% increase from the last price of $31.94. Detailed list of analyst forecasts

The 7 analysts offering 12-month price forecasts for Albireo Pharma Inc have a median target of 73.00, with a high estimate of 82.00 and a Chart ALBIREO PHARMA, INC. Technical analysis trends. Short Term, Mid-Term, Long Term. Trend, Bearish, Neutral Get today's Albireo Pharma Inc stock price and latest ALBO news as well as Albireo Pharma real-time stock quotes, technical analysis, full financials and more. including stock price quote, trading volume, volatility, options volume, statistics, and other important company data related to ALBO (Albireo Pharma) stock. Is Albireo Pharma (NASDAQ:ALBO) a buy? Compare the latest price, visualised quantitative ratios, annual reports, historical dividends, pricing and company Real-time share price updates and latest news for Albireo Pharma Inc (NASDAQ: ALBO).